macitentan, tadalafil (Yuvanci®)
Application Details
HSE100017
25009
macitentan, tadalafil
Yuvanci®
Johnson & Johnson Innovative Medicine (J&J IM)
17/02/2025
27/09/2024
Application Status
Awaiting Proposal from Applicant
12/09/2025
Applicant Meeting Held with CPU
12/09/2025
Proposal from Applicant Under Review
15/08/2025
Awaiting Proposal from Applicant
17/04/2025
Applicant Meeting Held with CPU
17/04/2025
Rapid Review Completed
11/03/2025
Pricing and Reimbursement Application Complete
17/02/2025
Rapid Review Commissioned
10/02/2025